Flags

Financial distress

Tempus AI

NSQ:TEM · US88023B1035

Life Sciences Tools & ServicesMedium

360

Value42

Profit price88

Cash yield1

Owner Earnings Yield1

Dividend Yield1

Sales & asset price31

Price/Sales58

EV / Gross Profit33

Price/Book3

Quality35

Returns on capital6

Return on Capital7

Cash Return on Capital11

Return on Equity1

Profit margins49

EBIT Margin11

Gross Profitability87

Cash backing46

Accruals71

Owner Earnings Margin21

Growth58

Sales growth88

Profit growth56

Reinvestment69

Price momentum17

Safety31

Debt load13

Debt serviceability33

Refinancing64

Debt Payback1

Liquidity53

Sentiment60

Analyst ratings23

Expectations trend66

Opinion Changes50

Price Target Upside81

Market mood81

Value Creation4/20not creating value

Creates more value than its capital costs
Owner earnings growing
Owner earnings per share growing
Reinvests at strong returns
Solid earnings base

What this means

Tempus AI doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA

IndustryLife Sciences Tools & Services

SizeMedium

TypePublic Company

ExchangeNASDAQGS

Founded2015

Employees2,619

Websiteinvestors.tempus.com

ISINUS88023B1035

Last UpdateApr 2, 2026

Indices

NASDAQ (USA)

Themes

Artificial IntelligenceGeneticsHealth DiagnosticsHematologyMachine LearningData IntegrationPredictive AnalyticsOncologyAnalyticsBiotechnologyClinical TrialsHealth CareMedicalSoftware

Description

Tempus AI, Inc. (Tempus) operates as a healthcare technology company. The company focuses on bringing artificial intelligence and machine learning to healthcare in order to improve the care of patients across multiple diseases. The company combines…

Analysis

Middle-of-the-road

Tempus AI, Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is stretched. The company scores 4/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250

2026

All-time high

Jun 2026

All-time low

Mar 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

100

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Tempus AI with its peers

Fulgent Genetics

NMQ:FLGT

CountryUSA

IndustryHealth Care Providers & Services

SizeMedium

Full Stock Analysis →

Champions Oncology

NAQ:CSBR

CountryUSA

IndustryLife Sciences Tools & Services

SizeSmall

Full Stock Analysis →

Quest Diagnostics

NYQ:DGX

CountryUSA

IndustryHealth Care Providers & Services

SizeX-Large

Full Stock Analysis →

Castle Biosciences

NMQ:CSTL

CountryUSA

IndustryHealth Care Providers & Services

SizeMedium

Full Stock Analysis →

OmniAb

NMQ:OABI

CountryUSA

IndustryLife Sciences Tools & Services

SizeSmall

Full Stock Analysis →

Alpha Teknova

NMQ:TKNO

CountryUSA

IndustryLife Sciences Tools & Services

SizeSmall

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →